Advertisement
Singapore markets open in 8 hours 2 minutes

  • Straits Times Index

    3,287.75
    -5.38 (-0.16%)
     

  • S&P 500

    5,032.43
    -39.20 (-0.77%)
     

  • Dow

    37,995.90
    -465.02 (-1.21%)
     

  • Nasdaq

    15,542.23
    -170.52 (-1.09%)
     

  • Bitcoin USD

    64,411.50
    -305.48 (-0.47%)
     

  • CMC Crypto 200

    1,386.47
    +3.89 (+0.28%)
     

  • FTSE 100

    8,078.86
    +38.48 (+0.48%)
     

  • Gold

    2,342.40
    +4.00 (+0.17%)
     

  • Crude Oil

    82.59
    -0.22 (-0.27%)
     

  • 10-Yr Bond

    4.6960
    +0.0440 (+0.95%)
     

  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     

  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     

  • FTSE Bursa Malaysia

    1,569.25
    -2.23 (-0.14%)
     

  • Jakarta Composite Index

    7,155.29
    -19.24 (-0.27%)
     

  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

Why Adaptimmune Therapeutics Stock Is Popping Today

George Budwell, The Motley Fool
·2-min read
Why Adaptimmune Therapeutics Stock Is Popping Today

Shares of the British cell therapy company Adaptimmune Therapeutics (NASDAQ: ADAP) are having one of their best days in several months today. To put this move into the proper context, the bellwether biotech indices -- the iShares Biotechnology ETF and the SPDR S&P Biotech ETF -- are both essentially flat for the day at the time of this writing. Adaptimmune's shares appear to be perking up in response to the buyout of fellow soft tissue cancer specialist Epizyme (NASDAQ: EPZM) earlier today.

Continue reading